Wednesday, October 21, 2020 at 12:00 PM to 1:20 PM · 1 hr. 20 min. (UTC)
Plenary keynote
Information
Pandemic responses: balancing act between public health responsibility and economic sustainability
How can we keep vaccine research, development and delivery sustainable for global health and prioritize equity?
How to approach infectious diseases, outbreaks and AMR pathogens that require considerable investment
Financing and access around vaccine R&D, vaccine manufacturing and vaccine procurement
Overview of global vaccine market and describing the characteristics of a healthy market (review of current frameworks)
Insights from the introduction of new vaccines and strategies that have been leveraged to encourage sustainable, sufficient, relevant, predictable supply to meet demand – what’s worked and what hasn’t in different contexts, including LMICs